Journal for ImmunoTherapy of Cancer · 2025-11-04
1119 TxGemma enables low-shot prediction of anti-PD-1 response in melanoma via immune gene expression
Phrase rank #1 · DOI 10.1136/jitc-2025-SITC2025.1119
Other observed topics
response
Observed in 214 articles across 34 journals.
Latest share0.22%
Change vs baseline-0.40 pp
Months observed13
Latest monthJul 2026
Portfolio article share
Attention over this snapshot
13 monthly points
Journal breadth
Where it appears
- Journal for ImmunoTherapy of Cancer83
- Gut26
- Lupus Science & Medicine18
- Thorax9
- BMJ Global Health8
- BMJ Open7
- Journal of Medical Ethics7
- Regional Anesthesia & Pain Medicine7
- Emergency Medicine Journal6
- Heart6
- BMJ Public Health4
- BMJ Supportive & Palliative Care3
Co-occurrence
Explore nearby topics
Inspect the source signal
Article evidence
30 high-ranking examples
Journal for ImmunoTherapy of Cancer · 2026-04-24
ILC2s and their immune checkpoints in the antitumor response
Phrase rank #2 · DOI 10.1136/jitc-2025-014183
Gut · 2025-10-06
P29 Efficacy and safety of seladelpar in patients with primary biliary cholangitis previously treated with fibrates or obeticholic acid
Phrase rank #2 · DOI 10.1136/gutjnl-2025-BASL.45
Heart · 2026-06-09
324 The response of human cardiac fibroblasts to cyclic tensile strain is pH- and TGFβ1-dependent
Phrase rank #3 · DOI 10.1136/heartjnl-2026-BCS.314
Lupus Science & Medicine · 2026-04-27
Evaluation of clinical, histological and biomarker response after initial therapy of lupus nephritis
Phrase rank #3 · DOI 10.1136/lupus-2025-001709
European Journal of Hospital Pharmacy · 2026-03-18
5PSQ-153 Predictive factors of response to ustekinumab and vedolizumab: development of machine learning algorithms for clinical response prediction in patients with inflammatory bowel disease
Phrase rank #3 · DOI 10.1136/ejhpharm-2026-eahp.578
BMJ Open · 2025-12-04
Enhancing integrated epidemic response mechanisms in humanitarian emergencies: a scoping review and qualitative study
Phrase rank #3 · DOI 10.1136/bmjopen-2025-102482
Journal for ImmunoTherapy of Cancer · 2025-11-04
53 Assessing the mechanism of action (MOA) of tisotumab vedotin (TV) in head and neck squamous cell carcinoma (HNSCC) with digital pathology analysis of H&E images from innovaTV207 part C
Phrase rank #3 · DOI 10.1136/jitc-2025-SITC2025.0053
Thorax · 2025-11-02
S54 Predictors of response to biologic therapy in a UK severe asthma population
Phrase rank #3 · DOI 10.1136/thorax-2025-BTSabstracts.60
Gut · 2025-10-06
P35 Change in pruritus in patients with primary biliary cholangitis and moderate to severe pruritus: a pooled analysis from the RESPONSE and ENHANCE studies
Phrase rank #3 · DOI 10.1136/gutjnl-2025-BASL.51
Gut · 2026-06-23
P62 Seladelpar linked to sustained reduction in cholestatic markers with consistent safety profile in PBC up to 48 months in ASSURE
Phrase rank #4 · DOI 10.1136/gutjnl-2026-BSG.198
Heart · 2026-06-09
505 Factors which govern diuretic response to acetazolamide – a post-hoc analysis of the ADA-HF trial
Phrase rank #4 · DOI 10.1136/heartjnl-2026-BCS.132
Journal for ImmunoTherapy of Cancer · 2026-03-11
Evaluation of mixed response in tumor size and survival in patients with rare cancers treated with dual checkpoint inhibitor therapy (DART SWOG S1609)
Phrase rank #4 · DOI 10.1136/jitc-2025-013260
RMD Open · 2026-03-09
Inflammation response criteria for rheumatoid arthritis based on the two-component disease activity score
Phrase rank #4 · DOI 10.1136/rmdopen-2025-006631
Journal for ImmunoTherapy of Cancer · 2025-11-07
1327 Biomarker and updated clinical data for RP1 plus nivolumab in anti-PD-1-failed melanoma from the IGNYTE trial demonstrate reversal of mechanisms of resistance to immune checkpoint blockade
Phrase rank #4 · DOI 10.1136/jitc-2025-SITC2025.1327
Journal for ImmunoTherapy of Cancer · 2025-11-04
60 Predictivity of an H&E-based method for response to PD-1 inhibition and the pathogenesis of CSCC using ENLIGHT-DP
Phrase rank #4 · DOI 10.1136/jitc-2025-SITC2025.0060
BMJ Global Health · 2025-11-03
Association between timeliness of detection, notification and response and the magnitude, severity and duration of disease outbreaks: a retrospective review of 84 outbreaks in Uganda, 2017–2022
Phrase rank #4 · DOI 10.1136/bmjgh-2025-020034
Regional Anesthesia & Pain Medicine · 2025-09-09
Letter: response to the letter by Dr Gregory Allen
Phrase rank #4 · DOI 10.1136/rapm-2025-107131
Journal for ImmunoTherapy of Cancer · 2025-09-04
The spontaneous neoantigen-specific CD4+ T-cell response to a growing tumor is functionally and phenotypically diverse
Phrase rank #4 · DOI 10.1136/jitc-2025-012209
BMJ Digital Health & AI · 2025-08-17
Smartphone barrier: uncovering the digital divide in mHealth prevention among disadvantaged middle-aged and older-aged UK communities
Phrase rank #4 · DOI 10.1136/bmjdhai-2025-000069
Sexually Transmitted Infections · 2026-06-05
P99 Immunological predictive factors for treatment response during bulevirtide therapy in HBV-HDV coinfected patients
Phrase rank #5 · DOI 10.1136/sextrans-ICAR-2026.140
BMJ Global Health · 2026-04-02
Process mapping the One Health response to a rabies outbreak in the Philippines
Phrase rank #5 · DOI 10.1136/bmjgh-2025-020482
Lupus Science & Medicine · 2026-03-18
Measurement of haemolytic anaemia in a novel treatment response measure for SLE clinical trials
Phrase rank #5 · DOI 10.1136/lupus-2025-001830
Lupus Science & Medicine · 2026-03-01
PO:11:283 Efficacy of anifrolumab in the treatment of cutaneous lupus erythematosus: a scoping review
Phrase rank #5 · DOI 10.1136/lupus-2026-el.337
Journal for ImmunoTherapy of Cancer · 2025-11-07
1343 A phase II trial of combination locoregional chemoimmunotherapy in recurrent platinum-sensitive ovarian cancer triggers a T lymphotactic response correlating with clinical outcomes
Phrase rank #5 · DOI 10.1136/jitc-2025-SITC2025.1343
Journal for ImmunoTherapy of Cancer · 2025-11-04
54 Development and characterization of cytokine-based classifiers to predict response to immunotherapy using an ex vivo live tumor fragment platform
Phrase rank #5 · DOI 10.1136/jitc-2025-SITC2025.0054
Journal for ImmunoTherapy of Cancer · 2025-09-21
Molecular response cutoffs and ctDNA collection timepoints influence on interpretation of associations between early changes in ctDNA and overall survival in patients treated with anti-PD(L)1 and/or chemotherapy
Phrase rank #5 · DOI 10.1136/jitc-2025-012454
Emergency Medicine Journal · 2026-06-29
Refocusing on science: the EMJ response
Phrase rank #6 · DOI 10.1136/emermed-2026-216350
Gut · 2026-06-23
P57 Improvements in moderate-to-severe pruritus patients with primary biliary cholangitis treated with seladelpar in up to 30 months of ASSURE
Phrase rank #6 · DOI 10.1136/gutjnl-2026-BSG.193
Thorax · 2026-05-14
Heterogeneity of short-term elexacaftor-tezacaftor-ivacaftor response in cystic fibrosis using 129Xe MRI
Phrase rank #6 · DOI 10.1136/thorax-2025-223687